Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of GLY-200 in adults with Type 2 diabetes mellitus to evaluate safety, tolerability, and pharmacodynamic effects; the study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLY-200

Snippet

Sponsor: Glyscend, Inc. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2025-02-10